Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response
Clinical trial NCT01610362 · COMPLETED
Trial details
- NCT number
- NCT01610362
- Sponsor
- Queen Saovabha Memorial Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2018-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.